| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 2.482 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 2.713 | 0 | 0 | 0 | 421 | 82.945 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 21.525 | 17.559 | 15.112 | 12.643 | 3.570 | 26.680 | -1.914 | 12 | 0 | 0 |
| Gross Profit/Loss - EUR | -18.811 | -17.559 | -15.112 | -12.643 | -3.148 | 56.266 | 1.914 | -12 | 0 | 0 |
| Net Profit/Loss - EUR | -18.811 | -17.559 | -15.112 | -12.643 | -3.153 | 53.777 | 1.914 | -12 | 0 | 0 |
| Employees | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Galmedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 86.279 | 81.614 | 76.546 | 71.674 | 66.885 | 43.037 | 44.203 | 44.340 | 44.206 | 43.959 |
| Current Assets | 59.820 | 57.288 | 52.341 | 51.275 | 50.885 | 132.964 | 48.084 | 48.222 | 48.076 | 47.807 |
| Inventories | 43.498 | 43.054 | 38.309 | 37.606 | 36.878 | 36.178 | 35.376 | 35.495 | 35.387 | 35.189 |
| Receivables | 14.328 | 14.101 | 13.845 | 13.591 | 13.328 | 95.846 | 12.448 | 12.486 | 12.449 | 12.379 |
| Cash | 1.994 | 132 | 187 | 78 | 679 | 939 | 260 | 241 | 240 | 239 |
| Shareholders Funds | -257.460 | -272.393 | -282.932 | -290.382 | -287.911 | -228.676 | -221.691 | -222.390 | -221.716 | -220.477 |
| Social Capital | 23.294 | 23.056 | 22.666 | 22.250 | 21.819 | 21.405 | 20.931 | 20.996 | 20.932 | 20.815 |
| Debts | 403.558 | 411.295 | 411.819 | 413.330 | 405.681 | 404.676 | 313.978 | 314.952 | 313.997 | 312.242 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Galmedica Srl